Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)

Conditions: Metastatic Castration-resistant Prostate Cancer Sponsors: AstraZeneca; Merck Sharp& Dohme LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials